Does the IL23R rs11209026 A allele dampen IL-23-dependent Th17 signaling and protect against Crohn disease?

The rs11209026 A allele in IL23R (p.Arg381Gln/R381Q) is a well-supported protective genetic factor for Crohn disease and related inflammatory bowel disease phenotypes. A GG genotype is the common non-carrier state and therefore does not confer this allele-associated protection; this is not equivalent to predicting disease in an individual 57-year-old man.

Clinical and genetic evidence

• Human genetic evidence consistently associates the A allele with substantially lower Crohn disease odds, with meta-analytic estimates around OR 0.41–0.43.
• A 41-study meta-analysis found reduced IBD risk across nearly all genetic models. Protection appears strongest and most consistent for Crohn disease, and may be less uniform for ulcerative colitis, ancestry, and disease phenotype.
• Thus, GG status means absence of the A-allele-associated risk reduction, rather than an independently determinative disease-causing genotype.

Mechanistic evidence

• R381Q is a hypomorphic IL23R variant: carrier studies demonstrate reduced IL-23-induced STAT3 activation, fewer IL-23-responsive T cells, and lower IL-23-driven IL-17A, IL-17F, and in some studies IL-22 production.
• The effect is selective for later IL-23-dependent Th17 effector and memory-cell responses; initial Th17 differentiation is largely retained. An allele-dose pattern has been reported, with stronger attenuation in homozygous carriers.

Microbial context

• Intestinal microbial sensing can induce IL-23, providing a biologically coherent setting in which reduced IL23R signaling could limit inflammatory Th17 responses.
• In healthy participants, A-allele carriage was associated with greater ileal microbial richness/diversity and Christensenellaceae-associated phylotypes. This supports genotype-associated microbial ecology, not proof that microbial triggers cause a selectively greater clinical effect in GG carriers.

Bottom line

• The core claim is strongly supported: the A allele dampens IL-23/Th17 signaling, and GG lacks its associated protection. The specific assertion that this difference operates when microbial triggers are present is biologically plausible, but not directly quantified in adequately powered human interaction studies.